These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18703482)

  • 1. Multiple biomarkers and cardiovascular risk.
    Pfister R; Hellmich M
    N Engl J Med; 2008 Aug; 359(7):760; author reply 761. PubMed ID: 18703482
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for cardiovascular risk assessment.
    Wolfert RL
    MLO Med Lab Obs; 2009 May; 41(5):14-6. PubMed ID: 19526891
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example].
    Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Jöckel KH; Erbel R;
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2023-6. PubMed ID: 19777421
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarker panels for cardiovascular risk assessment.
    de Lemos JA; Lloyd-Jones DM
    N Engl J Med; 2008 May; 358(20):2172-4. PubMed ID: 18480211
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 11. Superior predictive ability for death of a basic metabolic profile risk score.
    May HT; Horne BD; Ronnow BS; Renlund DG; Muhlestein JB; Lappé DL; Pearson RR; Carlquist JF; Kfoury AG; Bair TL; Rasmusson KD; Anderson JL
    Am Heart J; 2009 May; 157(5):946-54. PubMed ID: 19376326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin turning full circle as cardiovascular risk factor.
    Adiyaman A; Staessen JA
    Eur Heart J; 2007 Nov; 28(21):2557-8. PubMed ID: 17932427
    [No Abstract]   [Full Text] [Related]  

  • 13. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biomarkers for predicting cardiovascular events: lessons learned.
    Wang TJ
    J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin: a biomarker with many faces.
    Caidahl K; Ueland T; Aukrust P
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1684-6. PubMed ID: 20720194
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.
    Larsson TE; Olauson H; Hagström E; Ingelsson E; Arnlöv J; Lind L; Sundström J
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):333-9. PubMed ID: 19948843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.